查看購物車
  • Simplified Chinese
  • English
  • Japanese
2021-2031 年北美抗菌手術縫線市場報告（範圍、細分、動態和競爭分析）
市場調查報告書
商品編碼
1784612

2021-2031 年北美抗菌手術縫線市場報告（範圍、細分、動態和競爭分析）

North America Antimicrobial Surgical Suture Market Report 2021-2031 by Scope, Segmentation, Dynamics, and Competitive Analysis
出版日期: | 出版商: The Insight Partners | 英文 111 Pages | 訂單完成後即時交付

價格

北美抗菌手術縫線市場規模預計將從 2023 年的 1.5964 億美元增至 2031 年的 3.2952 億美元。預計 2024 年至 2031 年期間該市場的複合年成長率為 9.6%。

執行摘要和北美抗菌手術縫合線市場分析：

北美抗菌手術縫線市場分為美國、加拿大和墨西哥。 2023年，美國佔了最大的市場佔有率。隨著骨科手術、整形手術、心血管手術和剖腹產手術的增多，市場參與者對抗菌手術縫合線生產的關注度不斷提高，這推動了抗菌手術縫合線市場的發展。

北美抗菌手術縫合線市場細分分析：

有助於得出抗菌手術縫線市場分析的關鍵部分是類型、原料、應用和最終用戶。

根據類型，北美抗菌手術縫線市場細分為三氯生抗菌縫線和氯己定抗菌縫線。 2023年，三氯生抗菌縫線佔據了較大的市場佔有率。

根據原料，北美抗菌手術縫線市場細分為聚乳酸910抗菌縫線、聚卡普隆25和聚乙醇酸。聚乳酸910抗菌縫合線在2023年佔據了最大的市場佔有率。

根據應用，北美抗菌手術縫線市場細分為心血管外科、一般外科、眼科外科、婦科外科、骨科外科、整形外科、獸醫外科、牙科外科等。心血管外科在2023年佔據了最大的市場。

按最終用戶分類，北美抗菌手術縫合線市場分為醫院、門診手術中心和其他。 2023年，醫院佔據了最大的市場。

北美抗菌手術縫合線市場展望

根據美國外科醫師學會的數據，全球約有1-2%的人一生中可能會經歷一次慢性傷口。同樣，根據美國疾病管制與預防中心 (CDC) 的估計，美國醫護人員每年約有38.5萬起銳器傷，而這個數字很可能在一年內達到80萬起。除了銳器傷之外，全球其他類型的工作場所或職業傷害數量也在增加。根據國際勞工組織的數據，每年約有230萬人遭受工傷，影響他們的健康和生活品質。慢性傷口負擔的不斷增加最終推動了對先進傷口護理管理方法的需求，以大幅減輕國家醫療系統的財務負擔。各國在治療傷口和避免相關風險方面投入了大量資金。例如，在美國，醫療保健系統每年在治療傷口及其相關併發症方面的支出超過250億美元。因此，隨著慢性傷口發生率的上升，全球對抗菌手術縫線的需求也不斷增加。

此外，全球醫療機構進行的普通手術、心血管手術、骨科手術、婦科手術和癌症手術數量正在大幅增加。根據 Atrial Health 在 2023 年發布的資料，美國每年進行約 30 萬例心臟手術。此外，老年人口的成長導致了一些嚴重的健康問題（例如疝氣和白內障），這些問題需要手術作為主要治療選擇。老年人口容易罹患心血管疾病、骨科疾病、代謝性疾病和神經系統疾病等。據世界衛生組織稱，全球老齡人口可能會從 2019 年的約 10 億增加到 2050 年的約 21 億。美容手術在娛樂業的從業者中也變得很普遍。這些手術適用於患有意外或先天畸形的患者以及希望讓自己的外表更有吸引力的患者。因此，醫院或類似醫療機構進行的手術數量激增，推動了對抗菌手術縫合線的需求。

北美抗菌手術縫合線市場國家洞察

按國家分類，北美抗菌手術縫線市場包括美國、加拿大和墨西哥。美國在2023年佔最大佔有率。

由於烘焙食品和糖果產量的增加，美國抗菌手術縫合線市場預計將蓬勃發展。美國外科手術數量的增加以及美容整形手術支出的增加，正在推動市場的成長。根據美國整形外科醫師協會的數據，2018年，美國在美容整形手術上的支出達165億美元。美國山區/太平洋地區以美容整形手術聞名。美國已實施超過150萬例外科美容手術和超過550萬例非外科手術。

心血管疾病 (CVD) 和中風給美國帶來了巨大的健康負擔。根據美國心臟學會的報告，美國約有 80 萬人死於心血管疾病。冠心病是死亡的主要原因，其次是中風和心臟衰竭。然而，由於人們對先進醫療診斷、治療、醫療保險和報銷的認知不斷提高，過去十年因冠心病死亡的人數有所下降。因此，醫療療法的興起帶動了心血管、骨科和美容手術的增加。這反過來又將刺激對抗菌手術縫合線的需求。

北美抗菌手術縫合線市場公司簡介

市場上的一些主要參與者包括 Advanced MedTech Solutions Pvt. Ltd.、Cencora, Inc.（AmerisourceBergen Corporation）、Healthium Medtech Limited、Internacional Farmaceutica SA、強生公司、Meril Life Sciences Pvt Ltd、TI Medical 和 Unilene 等。這些參與者正在採取各種策略，例如擴張、產品創新和併購，以向消費者提供創新產品並增加市場佔有率。

北美抗菌手術縫合線市場研究方法：

本報告中的資料收集和分析遵循了以下方法：

二手資料研究：研究流程始於全面的二手資料研究，利用內部和外部資源收集每個市場的定性和定量資料。常用的二手資料研究來源包括但不限於：

公司網站、年度報告、財務報表、經紀商分析和投資者介紹。行業期刊及其他相關出版品。政府文件、統計資料庫和市場報告。針對在市場營運的公司的新聞文章、新聞稿和網路廣播。註：公司簡介部分所包含的所有財務資料均已標準化為美元。對於以其他貨幣報告的公司，數據已使用相應年份的相關匯率轉換為美元。

一手研究 Insight Partners 每年都會與行業利益相關者和專家進行大量的一手調查，以驗證其資料分析，並獲得寶貴的見解。這些研究訪談旨在：

驗證並完善二手資料研究的結果。提升分析團隊的專業知識和市場理解。深入了解市場規模、趨勢、成長模式、競爭動態和未來前景。一手資料研究透過電子郵件互動和電話訪談進行，涵蓋不同地區的各種市場、類別、細分市場和次細分市場。參與者通常包括：

產業利害關係人：副總裁、業務發展經理、市場情報經理和國家銷售經理外部專家：估值專家、研究分析師和具有行業專業知識的關鍵意見領袖

目錄

第1章：簡介

第2章：執行摘要

  • 關鍵見解

第3章：研究方法

  • 二次研究
  • 初步研究
    • 假設表述：
    • 宏觀經濟因素分析：
    • 顯影基數：
    • 數據三角測量：
    • 國家級資料：

第4章：北美抗菌手術縫線市場格局

  • PEST分析

第5章：北美抗菌手術縫合線市場-關鍵市場動態

  • 市場促進因素：
    • 手術部位感染盛行率激增
    • 慢性傷口和手術病例增加
  • 市場限制
    • 非侵入性縫合替代品
  • 市場機會
    • 抗菌外科縫合線的策略性舉措
  • 未來趨勢
    • 智慧抗菌縫合線
  • 促進因素和限制因素的影響：

第6章：抗菌手術縫合線市場－北美分析

  • 2021-2031年北美抗菌手術縫線市場收入
  • 北美抗菌手術縫合線市場預測分析

第7章：北美抗菌手術縫合線市場分析-按類型

  • 三氯生抗菌縫合線
  • 氯己定抗菌縫合線

第8章：北美抗菌手術縫合線市場分析-依原料

  • Polyglactin 910抗菌縫線
  • 聚卡普隆 25
  • 聚乙醇酸

第9章：北美抗菌手術縫合線市場分析-按應用

  • 心血管外科
  • 一般外科
  • 眼科手術
  • 婦科手術
  • 骨科手術
  • 整型手術
  • 獸醫外科
  • 牙科手術
  • 其他

第 10 章：北美抗菌手術縫線市場分析 - 按最終用戶

  • 醫院
  • 門診手術中心
  • 其他

第 11 章：北美抗菌手術縫線市場 - 國家分析

  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥

第 12 章：產業格局

  • 概述
  • 成長策略
    • 概述
  • 2023年公司市佔率分析（%）

第13章：公司簡介

  • TI Medical
  • Healthium Medtech Limited
  • Meril Life Sciences Pvt Ltd
  • Unilene
  • Johnson & Johnson
  • Cencora, Inc. (AmerisourceBergen Corporation)
  • Advanced MedTech Solutions Pvt. Ltd.
  • Internacional Farmaceutica SA

第 14 章：附錄

Product Code: BMIRE00031797

The North America antimicrobial surgical suture market size is expected to reach US$ 329.52 million by 2031 from US$ 159.64 million in 2023. The market is estimated to record a CAGR of 9.6% from 2024-2031.

Executive Summary and North America Antimicrobial Surgical Suture Market Analysis:

The North America antimicrobial surgical sutures market is segmented into the US, Canada, and Mexico. In 2023, the US held the largest share of the market. The increasing focus of market players on manufacturing antimicrobial surgical sutures due to the rise in orthopedic surgeries, plastic surgeries, cardiovascular surgeries, and C-section deliveries drives the antimicrobial surgical sutures market.

North America Antimicrobial Surgical Suture Market Segmentation Analysis:

Key segments that contributed to the derivation of the antimicrobial surgical suture market analysis are type, raw materials, application, and end user.

Based on type, the North America antimicrobial surgical suture market is sub segmented into triclosan antimicrobial suture and chlorhexidine antimicrobial suture. The triclosan antimicrobial suture held a larger share of the market in 2023.

By raw materials, the North America antimicrobial surgical suture market is segmented into polyglactin 910 antimicrobial suture, poliglecaprone 25, and polyglycolic acid. The polyglactin 910 antimicrobial suture segment held the largest share of the market in 2023.

By application, the North America antimicrobial surgical suture market is segmented into cardiovascular surgery, general surgery, ophthalmic surgery, gynecological surgery, orthopedic surgery, plastic surgery, veterinary surgery, dental surgery, and others. The cardiovascular surgery segment held the largest share of the market in 2023.

By end user, the North America antimicrobial surgical suture market is segmented into hospitals, ambulatory surgical centers, and others. The hospitals segment held the largest share of the market in 2023.

North America Antimicrobial Surgical Suture Market Outlook

According to the American College of Surgeons, ~1-2% of individuals in the world are likely to experience chronic wounds once in their lifetime. Similarly, as per the estimates from the Centers for Disease Control and Prevention (CDC), ~385,000 sharps injuries occur among healthcare workers in the US every year, and the number is likely to reach up to 800,000 injuries within one year. Besides sharp injuries, the number of other types of workplace or occupational injuries is increasing worldwide. According to the International Labor Organization, ~2.3 million people experience work-related injuries every year, affecting their health and quality of life. The soaring burden of chronic wounds eventually propels the demand for advanced wound care management methods to substantially reduce the financial burden from national healthcare systems. Various countries spend significant amounts of money on treating injuries and avoiding associated risks. For instance, in the US, the healthcare system spends over US$ 25 billion on treating wounds and related complications every year. Therefore, with the increasing incidence of chronic wounds, the demand for antimicrobial surgical sutures is also increasing worldwide.

Further, the number of general, cardiovascular, orthopedic, gynecological, and cancer surgeries performed in healthcare settings is increasing tremendously across the world. According to the data published by Atrial Health in 2023, ~300,000 cardiac surgeries are performed in the US every year. Moreover, the growing geriatric population contributes to severe health conditions (e.g., hernia and cataracts) that require surgeries as a primary treatment option. The geriatric population is prone to CVDs, orthopedic disorders, metabolic disorders, and neurological disorders, among others. According to the WHO, the aging population across the world is likely to rise from ~1 billion in 2019 to ~2.1 billion by 2050. Aesthetic surgeries have also become common among people working in the entertainment industry. These surgeries are performed on patients who have accidental or inherent deformities and on those who wish to make their appearance more appealing. Therefore, the surging number of surgeries performed in hospitals or similar healthcare institutions is driving the demand for antimicrobial surgical sutures.

North America Antimicrobial Surgical Suture Market Country Insights

Based on country, the North America antimicrobial surgical suture market comprises the US, Canada, and Mexico. The US held the largest share in 2023.

The US antimicrobial surgical suture market is expected to proliferate owing to the increased production of bakery and confectionery The increasing surgical procedure and the rising spending on cosmetic or plastic surgeries in the US are propelling the market growth. As per the American Society of Plastic Surgeons, in 2018, US$ 16.5 Billion was spent on cosmetic procedures in the US. The Mountain/Pacific region in the US is more famous for cosmetic surgeries. More than 1,500,000 surgical cosmetic operations and more than 5,500,000 nonsurgical procedures were carried out in the US.

Cardiovascular diseases (CVDs) and stroke produce immense health burdens in the US. According to the American College of Cardiology's reports, ~800,000 deaths were noted in the United States. The primary cause of death is coronary heart disease, followed by heart stroke and heart failure. However, deaths due to coronary heart disease have declined over the past decade due to the awareness of advanced medical diagnosis, treatments, medical insurance, and reimbursements. Therefore, the rise in medical therapies has led to an increase in cardiovascular, orthopedics, and cosmetic surgeries. This, in turn, will fuel the need for antimicrobial surgical sutures.

North America Antimicrobial Surgical Suture Market Company Profiles

Some of the key players operating in the market include Advanced MedTech Solutions Pvt. Ltd.; Cencora, Inc. (AmerisourceBergen Corporation); Healthium Medtech Limited; Internacional Farmaceutica SA; Johnson & Johnson; Meril Life Sciences Pvt Ltd; TI Medical; and Unilene among others. These players are adopting various strategies such as expansion, product innovation, and mergers and acquisitions to provide innovative products to their consumers and increase their market share.

North America Antimicrobial Surgical Suture Market Research Methodology :

The following methodology has been followed for the collection and analysis of data presented in this report:

Secondary Research The research process begins with comprehensive secondary research, utilizing both internal and external sources to gather qualitative and quantitative data for each market. Commonly referenced secondary research sources include, but are not limited to:

Company websites , annual reports, financial statements, broker analyses, and investor presentations. Industry trade journals and other relevant publications. Government documents , statistical databases, and market reports. News articles , press releases, and webcasts specific to companies operating in the market. Note: All financial data included in the Company Profiles section has been standardized to USD. For companies reporting in other currencies, figures have been converted to USD using the relevant exchange rates for the corresponding year.

Primary Research The Insight Partners' conducts a significant number of primary interviews each year with industry stakeholders and experts to validate its data analysis, and gain valuable insights. These research interviews are designed to:

Validate and refine findings from secondary research. Enhance the expertise and market understanding of the analysis team. Gain insights into market size, trends, growth patterns, competitive dynamics, and future prospects. Primary research is conducted via email interactions and telephone interviews, encompassing various markets, categories, segments, and sub-segments across different regions. Participants typically include:

Industry stakeholders : Vice Presidents, business development managers, market intelligence managers, and national sales managers External experts : Valuation specialists, research analysts, and key opinion leaders with industry-specific expertise

Table Of Contents

1. Introduction

  • 1.1 The Insight Partners Research Report Guidance
  • 1.2 Market Segmentation

2. Executive Summary

  • 2.1 Key Insights

3. Research Methodology

  • 3.1 Secondary Research
  • 3.2 Primary Research
    • 3.2.1 Hypothesis formulation:
    • 3.2.2 Macro-economic factor analysis:
    • 3.2.3 Developing base number:
    • 3.2.4 Data Triangulation:
    • 3.2.5 Country level data:

4. North America Antimicrobial Surgical Suture Market Landscape

  • 4.1 PEST Analysis

5. North America Antimicrobial Surgical Suture Market - Key Market Dynamics

  • 5.1 Market Drivers:
    • 5.1.1 Surging Prevalence of Surgical Site Infections
    • 5.1.2 Increasing Cases of Chronic Wounds and Surgeries
  • 5.2 Market Restraints
    • 5.2.1 Non-invasive Alternatives to Stitches
  • 5.3 Market Opportunities
    • 5.3.1 Strategic Initiatives in Antimicrobial Surgical Suture
  • 5.4 Future Trends
    • 5.4.1 Smart Antimicrobial Sutures
  • 5.5 Impact of Drivers and Restraints:

6. Antimicrobial Surgical Suture Market - North America Analysis

  • 6.1 North America Antimicrobial Surgical Suture Market Revenue (US$ Million), 2021-2031
  • 6.2 North America Antimicrobial Surgical Suture Market Forecast Analysis

7. North America Antimicrobial Surgical Suture Market Analysis - by Type

  • 7.1 Triclosan Antimicrobial Suture
    • 7.1.1 Overview
    • 7.1.2 Triclosan Antimicrobial Suture: North America Antimicrobial Surgical Suture Market - Revenue and Forecast to 2031 (US$ Million)
  • 7.2 Chlorhexidine Antimicrobial Suture
    • 7.2.1 Overview
    • 7.2.2 Chlorhexidine Antimicrobial Suture: North America Antimicrobial Surgical Suture Market - Revenue and Forecast to 2031 (US$ Million)

8. North America Antimicrobial Surgical Suture Market Analysis - by Raw Materials

  • 8.1 Polyglactin 910 Antimicrobial Suture
    • 8.1.1 Overview
    • 8.1.2 Polyglactin 910 Antimicrobial Suture: North America Antimicrobial Surgical Suture Market - Revenue and Forecast to 2031 (US$ Million)
  • 8.2 Poliglecaprone 25
    • 8.2.1 Overview
    • 8.2.2 Poliglecaprone 25: North America Antimicrobial Surgical Suture Market - Revenue and Forecast to 2031 (US$ Million)
  • 8.3 Polyglycolic Acid
    • 8.3.1 Overview
    • 8.3.2 Polyglycolic Acid: North America Antimicrobial Surgical Suture Market - Revenue and Forecast to 2031 (US$ Million)

9. North America Antimicrobial Surgical Suture Market Analysis - by Application

  • 9.1 Cardiovascular Surgery
    • 9.1.1 Overview
    • 9.1.2 Cardiovascular Surgery: North America Antimicrobial Surgical Suture Market - Revenue and Forecast to 2031 (US$ Million)
  • 9.2 General Surgery
    • 9.2.1 Overview
    • 9.2.2 General Surgery: North America Antimicrobial Surgical Suture Market - Revenue and Forecast to 2031 (US$ Million)
  • 9.3 Ophthalmic Surgery
    • 9.3.1 Overview
    • 9.3.2 Ophthalmic Surgery: North America Antimicrobial Surgical Suture Market - Revenue and Forecast to 2031 (US$ Million)
  • 9.4 Gynaecological Surgery
    • 9.4.1 Overview
    • 9.4.2 Gynaecological Surgery: North America Antimicrobial Surgical Suture Market - Revenue and Forecast to 2031 (US$ Million)
  • 9.5 Orthopedic Surgery
    • 9.5.1 Overview
    • 9.5.2 Orthopedic Surgery: North America Antimicrobial Surgical Suture Market - Revenue and Forecast to 2031 (US$ Million)
  • 9.6 Plastic Surgery
    • 9.6.1 Overview
    • 9.6.2 Plastic Surgery: North America Antimicrobial Surgical Suture Market - Revenue and Forecast to 2031 (US$ Million)
  • 9.7 Veterinary Surgery
    • 9.7.1 Overview
    • 9.7.2 Veterinary Surgery: North America Antimicrobial Surgical Suture Market - Revenue and Forecast to 2031 (US$ Million)
  • 9.8 Dental Surgery
    • 9.8.1 Overview
    • 9.8.2 Dental Surgery: North America Antimicrobial Surgical Suture Market - Revenue and Forecast to 2031 (US$ Million)
  • 9.9 Others
    • 9.9.1 Overview
    • 9.9.2 Others: North America Antimicrobial Surgical Suture Market - Revenue and Forecast to 2031 (US$ Million)

10. North America Antimicrobial Surgical Suture Market Analysis - by End User

  • 10.1 Hospitals
    • 10.1.1 Overview
    • 10.1.2 Hospitals: North America Antimicrobial Surgical Suture Market - Revenue and Forecast to 2031 (US$ Million)
  • 10.2 Ambulatory Surgical Centers
    • 10.2.1 Overview
    • 10.2.2 Ambulatory Surgical Centers: North America Antimicrobial Surgical Suture Market - Revenue and Forecast to 2031 (US$ Million)
  • 10.3 Others
    • 10.3.1 Overview
    • 10.3.2 Others: North America Antimicrobial Surgical Suture Market - Revenue and Forecast to 2031 (US$ Million)

11. North America Antimicrobial Surgical Suture Market - Country Analysis

  • 11.1 North America
    • 11.1.1 North America Antimicrobial Surgical Suture Market Overview
    • 11.1.2 North America Antimicrobial Surgical Suture Market - Breakdown, by Key Countries, 2023 and 2031 (%)
      • 11.1.2.1 United States: North America Antimicrobial Surgical Suture Market - Revenue and Forecast to 2031 (US$ Million)
        • 11.1.2.1.1 United States: North America Antimicrobial Surgical Suture Market Breakdown, by Type
        • 11.1.2.1.2 United States: North America Antimicrobial Surgical Suture Market Breakdown, by Raw Materials
        • 11.1.2.1.3 United States: North America Antimicrobial Surgical Suture Market Breakdown, by Application
        • 11.1.2.1.4 United States: North America Antimicrobial Surgical Suture Market Breakdown, by End User
      • 11.1.2.2 Canada: North America Antimicrobial Surgical Suture Market - Revenue and Forecast to 2031 (US$ Million)
        • 11.1.2.2.1 Canada: North America Antimicrobial Surgical Suture Market Breakdown, by Type
        • 11.1.2.2.2 Canada: North America Antimicrobial Surgical Suture Market Breakdown, by Raw Materials
        • 11.1.2.2.3 Canada: North America Antimicrobial Surgical Suture Market Breakdown, by Application
        • 11.1.2.2.4 Canada: North America Antimicrobial Surgical Suture Market Breakdown, by End User
      • 11.1.2.3 Mexico: North America Antimicrobial Surgical Suture Market - Revenue and Forecast to 2031 (US$ Million)
        • 11.1.2.3.1 Mexico: North America Antimicrobial Surgical Suture Market Breakdown, by Type
        • 11.1.2.3.2 Mexico: North America Antimicrobial Surgical Suture Market Breakdown, by Raw Materials
        • 11.1.2.3.3 Mexico: North America Antimicrobial Surgical Suture Market Breakdown, by Application
        • 11.1.2.3.4 Mexico: North America Antimicrobial Surgical Suture Market Breakdown, by End User

12. Industry Landscape

  • 12.1 Overview
  • 12.2 Growth Strategies
    • 12.2.1 Overview
  • 12.3 Company Market Share Analysis (%), 2023

13. Company Profiles

  • 13.1 TI Medical
    • 13.1.1 Key Facts
    • 13.1.2 Business Description
    • 13.1.3 Products and Services
    • 13.1.4 Financial Overview
    • 13.1.5 SWOT Analysis
    • 13.1.6 Key Developments
  • 13.2 Healthium Medtech Limited
    • 13.2.1 Key Facts
    • 13.2.2 Business Description
    • 13.2.3 Products and Services
    • 13.2.4 Financial Overview
    • 13.2.5 SWOT Analysis
    • 13.2.6 Key Developments
  • 13.3 Meril Life Sciences Pvt Ltd
    • 13.3.1 Key Facts
    • 13.3.2 Business Description
    • 13.3.3 Products and Services
    • 13.3.4 Financial Overview
    • 13.3.5 SWOT Analysis
    • 13.3.6 Key Developments
  • 13.4 Unilene
    • 13.4.1 Key Facts
    • 13.4.2 Business Description
    • 13.4.3 Products and Services
    • 13.4.4 Financial Overview
    • 13.4.5 SWOT Analysis
    • 13.4.6 Key Developments
  • 13.5 Johnson & Johnson
    • 13.5.1 Key Facts
    • 13.5.2 Business Description
    • 13.5.3 Products and Services
    • 13.5.4 Financial Overview
    • 13.5.5 SWOT Analysis
    • 13.5.6 Key Developments
  • 13.6 Cencora, Inc. (AmerisourceBergen Corporation)
    • 13.6.1 Key Facts
    • 13.6.2 Business Description
    • 13.6.3 Products and Services
    • 13.6.4 Financial Overview
    • 13.6.5 SWOT Analysis
    • 13.6.6 Key Developments
  • 13.7 Advanced MedTech Solutions Pvt. Ltd.
    • 13.7.1 Key Facts
    • 13.7.2 Business Description
    • 13.7.3 Products and Services
    • 13.7.4 Financial Overview
    • 13.7.5 SWOT Analysis
    • 13.7.6 Key Developments
  • 13.8 Internacional Farmaceutica SA
    • 13.8.1 Key Facts
    • 13.8.2 Business Description
    • 13.8.3 Products and Services
    • 13.8.4 Financial Overview
    • 13.8.5 SWOT Analysis
    • 13.8.6 Key Developments

14. Appendix

  • 14.1 About The Insight Partners
  • 14.2 Glossary of Terms

List Of Tables

  • Table 1. North America Antimicrobial Surgical Suture Market Segmentation
  • Table 2. North America Antimicrobial Surgical Suture Market - Revenue and Forecast to 2031 (US$ Million)
  • Table 3. United States: North America Antimicrobial Surgical Suture Market - Revenue and Forecast to 2031(US$ Million) - by Type
  • Table 4. United States: North America Antimicrobial Surgical Suture Market - Revenue and Forecast to 2031(US$ Million) - by Raw Materials
  • Table 5. United States: North America Antimicrobial Surgical Suture Market - Revenue and Forecast to 2031(US$ Million) - by Application
  • Table 6. United States: North America Antimicrobial Surgical Suture Market - Revenue and Forecast to 2031(US$ Million) - by End User
  • Table 7. Canada: North America Antimicrobial Surgical Suture Market - Revenue and Forecast to 2031(US$ Million) - by Type
  • Table 8. Canada: North America Antimicrobial Surgical Suture Market - Revenue and Forecast to 2031(US$ Million) - by Raw Materials
  • Table 9. Canada: North America Antimicrobial Surgical Suture Market - Revenue and Forecast to 2031(US$ Million) - by Application
  • Table 10. Canada: North America Antimicrobial Surgical Suture Market - Revenue and Forecast to 2031(US$ Million) - by End User
  • Table 11. Mexico: North America Antimicrobial Surgical Suture Market - Revenue and Forecast to 2031(US$ Million) - by Type
  • Table 12. Mexico: North America Antimicrobial Surgical Suture Market - Revenue and Forecast to 2031(US$ Million) - by Raw Materials
  • Table 13. Mexico: North America Antimicrobial Surgical Suture Market - Revenue and Forecast to 2031(US$ Million) - by Application
  • Table 14. Mexico: North America Antimicrobial Surgical Suture Market - Revenue and Forecast to 2031(US$ Million) - by End User
  • Table 15. Recent Growth Strategies in North America Antimicrobial Surgical Suture Market
  • Table 16. Glossary of Terms, Antimicrobial Surgical Suture Market

List Of Figures

  • Figure 1. North America Antimicrobial Surgical Suture Market Segmentation, by Country
  • Figure 2. PEST Analysis
  • Figure 3. North America Antimicrobial Surgical Suture Market - Key Market Dynamics
  • Figure 4. Impact Analysis of Drivers and Restraints
  • Figure 5. North America Antimicrobial Surgical Suture Market Revenue (US$ Million), 2021-2031
  • Figure 6. North America Antimicrobial Surgical Suture Market Share (%) - by Type (2023 and 2031)
  • Figure 7. Triclosan Antimicrobial Suture: North America Antimicrobial Surgical Suture Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 8. Chlorhexidine Antimicrobial Suture: North America Antimicrobial Surgical Suture Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 9. North America Antimicrobial Surgical Suture Market Share (%) - by Raw Materials (2023 and 2031)
  • Figure 10. Polyglactin 910 Antimicrobial Suture: North America Antimicrobial Surgical Suture Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 11. Poliglecaprone 25: North America Antimicrobial Surgical Suture Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 12. Polyglycolic Acid: North America Antimicrobial Surgical Suture Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 13. North America Antimicrobial Surgical Suture Market Share (%) - by Application (2023 and 2031)
  • Figure 14. Cardiovascular Surgery: North America Antimicrobial Surgical Suture Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 15. General Surgery: North America Antimicrobial Surgical Suture Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 16. Ophthalmic Surgery: North America Antimicrobial Surgical Suture Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 17. Gynaecological Surgery: North America Antimicrobial Surgical Suture Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 18. Orthopedic Surgery: North America Antimicrobial Surgical Suture Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 19. Plastic Surgery: North America Antimicrobial Surgical Suture Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 20. Veterinary Surgery: North America Antimicrobial Surgical Suture Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 21. Dental Surgery: North America Antimicrobial Surgical Suture Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 22. Others: North America Antimicrobial Surgical Suture Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 23. North America Antimicrobial Surgical Suture Market Share (%) - by End User (2023 and 2031)
  • Figure 24. Hospitals: North America Antimicrobial Surgical Suture Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 25. Ambulatory Surgical Centers: North America Antimicrobial Surgical Suture Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 26. Others: North America Antimicrobial Surgical Suture Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 27. North America Antimicrobial Surgical Suture Market Breakdown, by Key Countries - Revenue (2023) (US$ Million)
  • Figure 28. North America Antimicrobial Surgical Suture Market Breakdown, by Key Countries, 2023 and 2031 (%)
  • Figure 29. United States: North America Antimicrobial Surgical Suture Market - Revenue and Forecast to 2031(US$ Million)
  • Figure 30. Canada: North America Antimicrobial Surgical Suture Market - Revenue and Forecast to 2031(US$ Million)
  • Figure 31. Mexico: North America Antimicrobial Surgical Suture Market - Revenue and Forecast to 2031(US$ Million)